The Supreme Court on Monday announced it was granting review in Bruesewitz v. Wyeth, a test of the scope of the pre-emption provision of the National Childhood Vaccine Injury Act of 1986. It also noted that Chief Justice John Roberts Jr. “took no part” in the consideration or decision of the Court to take the case.

Though the justices almost never reveal their reasons for recusal, this one is almost certainly based on the fact that, as of the last financial disclosure form filed by Roberts in May 2009, he owned stock valued at $15,000 or less in Pfizer Inc. Pfizer acquired rival Wyeth in late 2009.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]